Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
- Fireside chat at 11:00 a.m. PT /
2:00 p.m. ET /7:00 p.m. IST
Goldman Sachs 45th Annual Global Healthcare Conference on
- Fireside chat at 7:40 a.m. PT /
10:40 a.m. ET /3:40 p.m. IST
Audio webcasts of the presentations will be available via the Investors section of the
About
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Contacts:
Investors:
Vice President, Head, Investor Relations
InvestorInfo@jazzpharma.com
Media:
Head of
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-june-investor-conferences-302158364.html
SOURCE